Altay Therapeutics
Eric Bjerkholt is an accomplished financial executive currently serving as Chief Financial Officer at Mirum Pharmaceuticals, Inc. since September 2023. Bjerkholt brings extensive experience from previous roles as Chief Financial Officer at Chinook Therapeutics, Inc. and Aimmune Therapeutics, as well as significant leadership at Sunesis Pharmaceuticals and IntraBiotics. Prior to these positions, Bjerkholt held the role of EVP Finance and Strategy at LifeSpring Nutrition and contributed to JP Morgan as Vice President. Educational credentials include an MBA from Harvard Business School and a Master's degree in Economics from the University of Oslo.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Altay Therapeutics
Altay Therapeutics uses a unique platform and drug development approach, Altay develops novel small molecule drugs targeting disease-causing transcription factors to treat chronic illnesses and cancers.